| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
21,050 |
14,317 |
$1.80M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
8,222 |
5,556 |
$937K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,701 |
2,705 |
$249K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,767 |
1,911 |
$217K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
7,118 |
3,568 |
$129K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,187 |
971 |
$125K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,928 |
1,204 |
$44K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,644 |
1,196 |
$37K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,352 |
2,227 |
$32K |
| 87428 |
|
254 |
215 |
$15K |
| 87430 |
|
1,261 |
808 |
$12K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
151 |
134 |
$10K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
171 |
142 |
$4K |
| 87400 |
|
697 |
229 |
$3K |
| 99384 |
|
14 |
14 |
$594.00 |
| 87807 |
|
83 |
36 |
$369.95 |
| 81003 |
|
183 |
160 |
$326.25 |
| 99051 |
|
252 |
146 |
$0.00 |